India's anti-obesity market is set for a price revolution as multiple pharmaceutical companies prepare to launch affordable generic versions of blockbuster weight-loss drugs Wegovy and Ozempic following patent expiry. With over six players entering the market on day one, prices are expected to drop significantly, potentially halving the monthly cost for patients and widening access to these crucial therapies.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/dXFl3th
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment